Network origin in David E. White first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David E. White via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Medical Specialties | Chief Executive Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Founder | |
| Brunel University | College/University | Graduate Degree | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | President | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Medical/Nursing Services | Corporate Officer/Principal | |
| University of Leeds | College/University | Graduate Degree | |
| Colby College | College/University | Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin | |
| Providence College | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Massachusetts | College/University | Undergraduate Degree | |
MYOSIX SA
 MYOSIX SA BiotechnologyHealth Technology MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France. | Biotechnology | Chief Executive Officer | |
| MG Biotherapeutics LLC | Chief Operating Officer | ||
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree | |
| University of Strasbourg | College/University | Undergraduate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maisons & Cités d'HLM
 Maisons & Cités d'HLM Real Estate DevelopmentFinance Maisons & Cités d'HLM provides real estate services. It offers builds social housing, as well as offers renting, selling, and buying of properties. The company was founded on December 31, 1985 and is headquartered in Douai, France. | Real Estate Development | Chairman | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Corporate Officer/Principal | |
| Groupe de Sup de Co La Rochelle | College/University | Graduate Degree | |
| VALNEVA | Biotechnology | Corporate Officer/Principal | |
| F.W. Olin Graduate School of Business | College/University | Masters Business Admin | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
Red Oak Medicines, Inc.
 Red Oak Medicines, Inc. Pharmaceuticals: MajorHealth Technology Red Oak Medicines, Inc. engages in the provision of pharmaceuticals. The company is headquartered in Natick, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| French American Chamber of Commerce New England | Director/Board Member | ||
| Louis Pasteur University | College/University | Undergraduate Degree | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 25 |
| France | 13 |
| United Kingdom | 4 |
| Germany | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 17 |
| Health Services | 4 |
| Finance | 3 |
Operational
| Corporate Officer/Principal | 20 |
| Undergraduate Degree | 8 |
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| Graduate Degree | 4 |
Most connected contacts
| Insiders | |
|---|---|
| Frédéric Chéreau | 17 |
| Michael Franken | 9 |
| Matthias Hebben | 6 |
| Tom Wilton | 5 |
| Jonathan Quick | 4 |
| Marie Payton | 4 |
| Janice Olson | 3 |
| Grace Lochhead | 2 |
| Sven Loebrich | 1 |
- Stock Market
- Insiders
- David E. White
- Company connections
